Free Trial
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Price, News & Analysis

Pharming Group logo
$0.91 0.00 (0.00%)
As of 05/2/2025

About Pharming Group Stock (OTCMKTS:PHGUF)

Key Stats

Today's Range
$0.91
$0.91
50-Day Range
$0.79
$0.93
52-Week Range
$0.75
$0.99
Volume
N/A
Average Volume
15,292 shs
Market Capitalization
$612.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Pharming Group (PHAR) Receives a Buy from H.C. Wainwright
Pharming price target raised to $39 from $30 at Oppenheimer
See More Headlines

PHGUF Stock Analysis - Frequently Asked Questions

Pharming Group's stock was trading at $0.9815 at the beginning of the year. Since then, PHGUF shares have decreased by 7.0% and is now trading at $0.9130.
View the best growth stocks for 2025 here
.

Pharming Group (OTCMKTS:PHGUF) posted its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a negative trailing twelve-month return on equity of 7.65% and a negative net margin of 6.09%.

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/05/2015
Today
5/04/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:PHGUF
Previous Symbol
OTC:PHGUF
CIK
N/A
Employees
382
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,550,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$245.32 million
Cash Flow
$0.01 per share
Price / Cash Flow
89.78
Book Value
$0.33 per share
Price / Book
2.77

Miscellaneous

Free Float
N/A
Market Cap
$612.69 million
Optionable
Not Optionable
Beta
0.87

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:PHGUF) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners